Holen Sie sich die Stockscreener-App
96.24
1.72%
-1.68
Handel nachbörslich:
96.24
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$97.92
Offen:
$98.08
24-Stunden-Volumen:
16.01M
Relative Volume:
1.57
Marktkapitalisierung:
$251.88B
Einnahmen:
$63.17B
Nettoeinkommen (Verlust:
$12.15B
KGV:
20.18
EPS:
4.77
Netto-Cashflow:
$14.84B
1W Leistung:
-3.42%
1M Leistung:
-1.85%
6M Leistung:
-23.48%
1J Leistung:
-19.05%
1-Tages-Spanne:
$95.76
$98.27
1-Wochen-Bereich:
$95.76
$100.89
52-Wochen-Spanne:
$94.48
$134.63
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
2000 GALLOPING HILL ROAD, KENILWORTH, NJ
Vergleichen Sie MRK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
96.24 | 251.88B | 63.17B | 12.15B | 14.84B | 4.77 |
|
LLY
Lilly Eli Co
|
742.35 | 705.53B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
81.03 | 359.79B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
148.15 | 344.63B | 87.70B | 14.68B | 19.03B | 6.05 |
|
ABBV
Abbvie Inc
|
172.61 | 305.03B | 55.53B | 5.12B | 15.62B | 2.88 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Merck & Co., Inc. (NYSE:MRK) Given New $113.00 Price Target at Morgan Stanley - MarketBeat
Ballentine Partners LLC Sells 2,667 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Zhang Financial LLC Purchases 4,116 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Central Bank & Trust Co. - MarketBeat
Can the 8 Worst-Performing Dow Jones Stocks in 2024 Beat the S&P 500 in 2025? - The Motley Fool
Harbor Investment Advisory LLC Raises Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
BigSur Wealth Management LLC Increases Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Position Decreased by MassMutual Private Wealth & Trust FSB - MarketBeat
Diversify Wealth Management LLC Has $2.01 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck: 3x Pipeline And Undervaluation Make It A Buy (NYSE:MRK) - Seeking Alpha
Merck & Co., Inc. (MRK): A Bull Case Theory - MSN
AHL Investment Management Inc. Invests $269,000 in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Annex Advisory Services LLC Trims Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Brady Martz Wealth Solutions LLC Acquires Shares of 17,939 Merck & Co., Inc. (NYSE:MRK) - MarketBeat
High-Quality Dividend Growth Stocks Near 52-Week Lows: Merck Is Magnificent - Seeking Alpha
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Ameritas Advisory Services LLC - MarketBeat
Jim Cramer on Merck & Co., Inc. (MRK): ‘Right Now, The Stock’s Well-ensconced A Few Points Around 52-week Low’ - Insider Monkey
Folger Nolan Fleming Douglas Capital Management Inc. Has $6.91 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Cadinha & Co. LLC Reduces Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Bought by Moss Adams Wealth Advisors LLC - MarketBeat
Wealth Alliance Advisory Group LLC Reduces Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Kera Capital Partners Inc. Purchases New Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Jackson Square Capital LLC Sells 15,684 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
HB Wealth Management LLC Increases Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Integrated Investment Consultants LLC Has $62.33 Million Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Holdings Lifted by Merit Financial Group LLC - MarketBeat
Arkadios Wealth Advisors Decreases Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Brooklyn Investment Group Sells 2,794 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
How Is Merck's Stock Performance Compared to Other Pharmaceuticals Stocks? - MSN
Is Merck & Co., Inc. (MRK) the Best Cheap Stock to Buy for 2025? - Insider Monkey
Exclusive: Kennedy played key role in Gardasil vaccine case against Merck - Reuters
Householder Group Estate & Retirement Specialist LLC Sells 4,613 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Relyea Zuckerberg Hanson LLC Purchases 3,131 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Hennessy Advisors Inc. Increases Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Bought by Carnegie Investment Counsel - MarketBeat
Yarger Wealth Strategies LLC Invests $252,000 in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Stock Price | MRK Stock Quote, News, and History - Markets Insider
Purdue teams with Lilly, Merck to launch pharma manufacturing initiative - Inside INdiana Business
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Guggenheim cuts Merck stock target, retains Buy on revised estimates - MSN
Drug Discovery Market Generated Opportunities, Future Scope by 2031 | Pfizer Inc., GlaxoSmithKline LLC, Merck - EIN News
KMG Fiduciary Partners LLC Acquires 14,161 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Empirical Asset Management LLC Raises Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Eagle Rock Investment Company LLC Sells 13,523 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Purdue aims to speed evolution of pharma manufacturing in collaboration with Lilly and Merck - Purdue University
Merck & Co., Inc. (NYSE:MRK) Stake Lessened by Salvus Wealth Management LLC - MarketBeat
Tallon Kerry Patrick Acquires Shares of 3,679 Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Gateway Investment Advisers LLC - MarketBeat
7MM Type 1 Diabetes Market Drug Forecast and Market Analysis 2023-2024 & 2033: Value to Reach $9.91 Billion - GlobeNewswire Inc.
Merck Defends 3rd Circ. Win In Mumps Vaccine Antitrust Case - Law360
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):